Fotini Kaloyirou

Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial

Tian Zhao, Charmaine Griffiths, Emma L Arbon et al. · BMJ Open · 2018 · 111 citations · Full text

Medicine, Cardiology, Immunology +17

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease

Tian Zhao, Rouchelle Sriranjan, Zewen Kelvin Tuong et al. · NEJM Evidence · 2021 · 62 citations · Full text

Life Sciences, Cardiology, Immunology +12

Defatting of donor transplant livers during normothermic perfusion—a randomised clinical trial: study protocol for the DeFat study

Syed Hussain Abbas, Carlo Ceresa, Leanne Hodson et al. · Trials · 2024 · 17 citations · Full text

Medicine, Surgery, Metabolic Stability +13

Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization

Heli Harvala, Dung Nguyen, Peter Simmonds et al. · Transfusion · 2022 · 12 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17